A Win For Calithera Biosciences, Inc.
Thu, Jul 27, 2023 at 07:37 PM
Calithera Biosciences, Inc. (CALA:NASDAQ) soared at $0.08, representing a gain of 105%. On Thu, Jul 27, 2023, CALA:NASDAQ hit a New 2-Week High of $0.08. From Thu, Jul 13, 2023, the stock recorded 22.22% Up Days and 20.00% Green Days
About Calithera Biosciences, Inc. (CALA:NASDAQ)
Calithera Biosciences Inc is a clinical-stage biopharmaceutical company focused on discovering and developing novel small molecule drugs directed against tumor metabolism and tumor immunology targets for the treatment of cancer.
Top 10 Gainers:
- Statera Biopharma Inc. (STAB:NASDAQ), 616.67%
- Femasys Inc. (FEMY:NASDAQ), 130.77%
- Calithera Biosciences, Inc. (CALA:NASDAQ), 105%
- UroGen Pharma Ltd. (URGN:NASDAQ), 98.56%
- Greenbrook TMS Inc. (GBNH:NASDAQ), 90.38%
- Tupperware Brands Corporation (TUP:NYSE), 56.32%
- Colombier Acquisition Corp. Class A (CLBR:NYSE), 54.51%
- Ultralife Corporation (ULBI:NASDAQ), 52.54%
- Carmell Therapeutics Corporation Class A Common Stock (CTCX:NASDAQ), 46%
- View Inc. (VIEW:NASDAQ), 44.36%